Unlock instant, AI-driven research and patent intelligence for your innovation.

NGF (Nerve Growth Factor) gene and PEI (Polyether Imide) derivative nano-particle compound and preparing method and application thereof

A nanoparticle and derivative technology, applied in other methods of inserting foreign genetic materials, gene therapy, drug combination, etc., to achieve uniform particle size distribution, strong DNA binding ability, and high transfection efficiency.

Inactive Publication Date: 2014-12-31
XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] At present, there is no report on the use of nanoparticle complexes composed of NGF gene and PEI derivatives formed by copolymerization of low molecular weight PEI and phthalaldehyde, pyridinedicarbaldehyde, pyridazinedicarbaldehyde or imidazoledicarbaldehyde to treat Parkinson's disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • NGF (Nerve Growth Factor) gene and PEI (Polyether Imide) derivative nano-particle compound and preparing method and application thereof
  • NGF (Nerve Growth Factor) gene and PEI (Polyether Imide) derivative nano-particle compound and preparing method and application thereof
  • NGF (Nerve Growth Factor) gene and PEI (Polyether Imide) derivative nano-particle compound and preparing method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 Preparation of NGF gene-PEI derivative nanoparticle complex

[0046] Weigh a certain amount of PEI derivatives (PEI and imidazole dicarbaldehyde to form a copolymer, the weight average molecular weight of PEI is 1500Da, X is 2,5-imidazole dicarbaldehyde) and dissolve it in water so that the concentration is 2.0 mg / ml, passing through 0.45 μm water After membrane filtration, it is ready for use; draw a certain amount of NGF gene solution and dilute it with water to form a 20 μg / ml NGF gene stock solution. When preparing the complex of PEI derivatives and NGF gene nanoparticles, according to the set mass ratio of a series of PEI derivatives and NGF genes, the PEI derivative solution is diluted to the corresponding concentration, and then quickly added to the same volume of NGF with a fixed concentration In the gene solution, make the final concentration of NGF gene 20 μg / ml, and finally mix the solution evenly at 1000 rpm, and incubate at room temperature for 2...

Embodiment 2

[0047] Example 2 Agarose gel electrophoresis of NGF gene-PEI derivative nanoparticle complex

[0048] Weigh 1.0 g of agarose, add 100 ml of 1×TAE buffer, heat and dissolve in a microwave oven, wait until the temperature drops to 65°C, add ethidium bromide (EB) to prepare a 1.0% agarose solution (containing 0.5 μg / ml ethidium bromide), pour it into the gel-making tank, insert the sample comb, and let it stand at room temperature for 0.5-1 hour until the gel solidifies. Then, pull out the sample comb, add TAE buffer to the electrophoresis tank to cover the gel, and wait for the sample to be loaded. Next, with reference to the preparation method of the nanoparticle composite solution in Example 1, nanoparticle composite solutions with different mass ratios were prepared, and the mass ratios of PEI derivatives and NGF genes in the nanoparticle composite solution were 0, 1, 2, 3, 5, 7, 10, 15, 20, 30, 50, 70, 80, 100. Marker chooses DS TM 5000 (100 – 5000 bp), load 2 μl; 6× loa...

Embodiment 3

[0049] Example 3 Transmission electron microscope observation of NGF gene-PEI derivative nanoparticle complex

[0050] According to the preparation method of the nanoparticle complex solution in Example 1, a nanoparticle complex solution with a mass ratio of PEI derivative to NGF gene of 30 was prepared, and the sample volume was 100 μl. First, 10 μl of the nanoparticle complex solution was slowly dropped on a 400-mesh copper grid, and dried naturally at room temperature. Finally, a transmission electron microscope was used to observe the shape of the sample, and the transmission electron microscope picture was recorded. Transmission electron microscopy shows that: PEI derivatives are added to NGF gene molecules, complexed by electrostatic force to form a complex, showing spherical nanoparticles, and its shape is regular and uniform. It is obvious that NGF gene molecules are wrapped in polymers. Inside, the nanoparticles have a particle size of 150 - 300 nm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle sizeaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to an NGF (Nerve Growth Factor) gene and PEI (Polyether Imide) derivative nano-particle compound and a preparing method and application thereof. The nano-particle compound comprises an NGF gene substance and a PEI derivative, wherein the ratio by mass of the PEI derivative to the NGF gene substance is 15-80, the PEI is low-molecular polyether imide, the weight average molecular weight is smaller than or equal to 2000 Da, and X refers to phthalaldehyde, pyridinedicarboxaldehyde, piperazinedicarboxaldehyde or disimidazole-2,2'-dialdehydes. The nano-particle compound provided by the invention has small toxicity and high transfection efficiency. The stability before reaching target cells and the biological responsibility after entering the target cells can be combined in the in-vivo circulation process, and the non-toxic metabolism of polycation ions can be finished in vivo by selves, so that the nano-particle compound can be used for treating Parkinson's disease and complications thereof through intracranial local injection.

Description

technical field [0001] The invention relates to the technical field of non-viral gene vectors, in particular to the NGF gene-PEI derivative nano particle complex and its preparation method and application. Background technique [0002] During the development of gene therapy, the study of gene delivery system, that is, gene carrier, has always been the focus of attention. Whether the gene carrier can safely and effectively carry genes to designated locations is the key to whether gene therapy can be applied clinically. Gene vectors can be divided into two categories: viral vectors and non-viral vectors. Although the viral vector is still the most used at present, its transfection efficiency can reach more than 90%, but the viral vector has its own insurmountable limitations, such as the ability to induce host immune response and potential carcinogenicity, the preparation is complicated, and the The limited size of loaded exogenous DNA greatly limits its application. Therefo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K48/00A61K9/14A61P25/16A61P25/14C12N15/87
Inventor 袁伟恩刘振国原明璐车俊怡
Owner XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE